Sentence examples for surviving rate from inspiring English sources

(e^{-m tau_{1}}) denotes the surviving rate of infected cells during the delay period.

(e^{-n tau_{2}}) denotes the surviving rate of a virus during the delay period.

We assume that the immature predators suffer a mortality rate of (d_{1}) (the through-stage death rate) and take τ units of time to mature; thus (e^{-d_{1}tau}) is the surviving rate of each immature predator to reach maturity.

The research results showed that DnaK gene after induction of IPTG demonstrate a significant improvement of resistance of recombinant E. coli BL21 DnaK against high temperature and acidity, which mainly indicated by considerable increases in surviving rate and D-values of recombinant BL21 DnaK comparing to wild BL21.

To calculate the surviving probability, we have that (V_{1}(t)) satisfies the following equation for all t between the age of 8 month and 8 (mathrm{months}+tau): frac{{ d}V_{1}(t)}{{ d}t}=-d^{prime}V_{1}(t), and thus we have (V_{1}(t+tau)=V_{1}(t) cdot e^{-d^{prime}tau}), and we get the surviving rate (V_{1}(t+tau /V_{1}(t)= e^{-d^{prime}tau}).

Among these, the combination of 3.4 mg/Kg TA 0.54 mM in saline +1.6 mg/Kg TB-YK 0.19 mM in saline/mouse (75 µg TA+35 µg TB in 100 µl saline) was chosen for further studies because provided the highest surviving rate of mice infected with gram positive and gram negative bacteria and did not display haemolytic activity.

The confounding variables were chosen according to the Standardization or Adjustment method: we applied the cumulative proportion surviving rates generated in each of our four strata (stent, chemotherapy, radiotherapy, chemoradiotherapy) to the same "standard" theoretical population.

However, by using chemotherapy, the long term survive rate of NSCLC is only 10 15 %, and chemotherapy resistance is one of the main reasons leading to the failure of chemotherapy [ 1, 2].

During the study period, 377 consecutive patients were admitted in ICUs with AKI treated by RRT in which 179 survived (survival rate 47.4 %).

As many as half of us are expected to experience cancer by 2020, and thanks to phenomenal advances in medical care many more are surviving – survival rates are increasing at a rate of 3% every year.

While only 20% of the control mice survived, the survival rate of M-CyldΔ9 mice reached 80%.